- 30 June 2022
- journal article
- review article
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 17 (16) , e202200451
Abstract
RNA interference (RNAi) is a primitive evolutionary mechanism developed to escape incorporation of foreign genetic material. siRNA has been instrumental in achieving the therapeutic potential of RNAi by theoretically silencing any gene of interest in a reversible and sequence‐specific manner. Extrinsically administered siRNA generally needs a delivery vehicle to span across different physiological barriers and load into the RISC complex in the cytoplasm in its functional form to show its efficacy. This review discusses the designing principles and examples of different classes of delivery vehicles that have proved to be efficient in RNAi therapeutics. We also briefly discuss the role of RNAi therapeutics in genetic and rare diseases, epigenetic modifications, immunomodulation and combination modality to inch closer in creating a personalized therapy for metastatic cancer. At the end, we present, strategies and look into the opportunities to develop efficient delivery vehicles for RNAi which can be translated into clinics.Keywords
Funding Information
- Indian Institute of Science Education and Research Kolkata
This publication has 298 references indexed in Scilit:
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Role of the Methoxy Group in Immune Responses to mPEG-Protein ConjugatesBioconjugate Chemistry, 2012
- Protein Modification with Amphiphilic Block Copoly(2-oxazoline)s as a New Platform for Enhanced Cellular DeliveryMolecular Pharmaceutics, 2010
- Effect of Nanoparticle Conjugation on Gene Silencing by RNA InterferenceJournal of the American Chemical Society, 2010
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials, 2010
- Determination of Penetratin Secondary Structure in Live Cells with Raman MicroscopyJournal of the American Chemical Society, 2009
- Enhanced skin penetration of P20 phosphopeptide using protein transduction domainsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Cell-penetrating peptides: tools for intracellular delivery of therapeuticsCellular and Molecular Life Sciences, 2005